Dr. Micheal Hebert focuses his practice on counseling clients on strategies for maximizing intellectual property protection and leveraging such protection in several areas of the life sciences. His practice includes drafting and prosecuting patent applications in genetics, personalized medicine, gene therapy, virology, antibodies, stem cells, pharmaceuticals, and microbiology. Micheal also has extensive experience conducting due diligence research and analysis for freedom-to-operate investigations, patent validity opinions, patentability opinions, and technology licensing. In conducting due diligence research, Micheal is proficient in searching patent databases, nonpatent literature databases, and nucleic/amino acid sequence alignment databases.
Micheal's practice also includes an emphasis on licensing and other commercial transactions in the life sciences. He assists clients in matters relating to transfer of intellectual property rights and collaborations between parties, including drafting and negotiating license agreements and joint development agreements. He also performs due diligence assessments of transactions involving the acquisition and transfer of intellectual property rights.
Prior to joining Jones Day, Micheal was a patent agent and scientific advisor at two international law firms and a postdoctoral fellow at Stanford University in the field of human gene therapy and viral vector development. While at Stanford, he was the recipient of the National Hemophilia Foundation Judith Graham Pool Postdoctoral Fellowship and was awarded a National Research Service Award from the NIH. While earning his Ph.D. at the University of Texas at Houston Health Science Center, Micheal worked in the areas of hereditary neurological diseases, DNA structure, and cellular mechanisms of recombination, repair, and replication.
- October 2006
Gene Replacement Therapy for Hemophilia B, National Hemophilia Foundation 58th Annual Meeting
- June 2006
Treatment for Hemophilia B using Self-complimentary AAV8 Vectors, American Society of Gene Therapy 2006 Annual Meeting
- University of San Diego (J.D. 2015); The University of Texas at Houston (Ph.D. in Human and Molecular Genetics 2005; Schissler Foundation Fellowship); State University of New York Plattsburgh (B.S. in Cellular Biochemistry 1998)
- California and registered to practice before the U.S. Patent and Trademark Office